US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
CN1138533C
(zh)
*
|
1996-09-13 |
2004-02-18 |
利普森有限公司 |
脂质体
|
US7384923B2
(en)
|
1999-05-14 |
2008-06-10 |
Lipoxen Technologies Limited |
Liposomes
|
DE69710599T2
(de)
*
|
1996-10-25 |
2003-03-06 |
Monsanto Technology Llc |
Zusammensetzung und verfahren zur behandlung von pflanzen mit exogenen chemikalien
|
JP4160123B2
(ja)
|
1996-10-25 |
2008-10-01 |
モンサント・テクノロジー・エルエルシー |
外因性化学物質により植物を処理するための組成物および方法
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
AU5794598A
(en)
|
1996-12-13 |
1998-07-03 |
Patricia Tekamp-Olson |
Method for expression of heterologous proteins in yeast
|
US5891467A
(en)
*
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
US6106858A
(en)
*
|
1997-09-08 |
2000-08-22 |
Skyepharma, Inc. |
Modulation of drug loading in multivescular liposomes
|
ATE535232T1
(de)
|
1997-09-18 |
2011-12-15 |
Pacira Pharmaceuticals Inc |
Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
US6914131B1
(en)
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
AU752802C
(en)
|
1997-11-14 |
2006-04-13 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
PT1047784E
(pt)
|
1998-01-14 |
2009-12-21 |
Novartis Vaccines & Diagnostic |
Antigénios de neisseria meningitidis
|
WO1999057280A2
(en)
|
1998-05-01 |
1999-11-11 |
Chiron Corporation |
Neisseria meningitidis antigens and compositions
|
DE69938190T2
(de)
|
1998-10-15 |
2009-03-05 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
|
ATE408695T1
(de)
|
1998-12-16 |
2008-10-15 |
Novartis Vaccines & Diagnostic |
Menschliche cyclin-abhängige kinase (hpnqalre)
|
IL144561A0
(en)
*
|
1999-01-25 |
2002-05-23 |
Optime Therapeutics Inc |
Liposome compositions and methods for treating pests utilizing the same
|
PT1228217E
(pt)
|
1999-04-30 |
2013-01-28 |
Novartis Vaccines & Diagnostic |
Antígenos de neisseria conservados
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
DK1808438T3
(da)
|
1999-06-29 |
2014-10-27 |
Mannkind Corp |
Rensning og stabilisering af peptid og proteiner i lægemidler
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CN101613397A
(zh)
|
1999-10-29 |
2009-12-30 |
启龙股份公司 |
奈瑟球菌的抗原性肽
|
ES2335386T3
(es)
|
1999-11-18 |
2010-03-26 |
Novartis Vaccines And Diagnostics, Inc. |
Gen fgf-21 humano y productos de expresion genica.
|
EP1251837A2
(en)
|
1999-12-23 |
2002-10-30 |
Neurochem, Inc. |
Compounds and methods for modulating cerebral amyloid angiopathy
|
CN102172398A
(zh)
|
2000-01-17 |
2011-09-07 |
诺华疫苗和诊断有限公司 |
含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗
|
AU2001239488B2
(en)
|
2000-02-28 |
2006-01-19 |
Glaxosmithkline Biologicals S.A. |
Heterologous expression of neisserial proteins
|
WO2001066595A2
(en)
|
2000-03-08 |
2001-09-13 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
JP5363695B2
(ja)
|
2000-06-15 |
2013-12-11 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
結腸癌に関するポリヌクレオチド
|
NZ594877A
(en)
|
2000-10-27 |
2012-07-27 |
Novartis Vaccines & Diagnostic |
Nucleic acids and proteins from streptococcus groups A & B
|
EP2336368A1
(en)
|
2000-12-07 |
2011-06-22 |
Novartis Vaccines and Diagnostics, Inc. |
Endogenous retroviruses up-regulated in prostate cancer
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
AU2002305151A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
JP3966819B2
(ja)
|
2001-05-24 |
2007-08-29 |
キム,スーギョン |
毛嚢に存在する新規の第2ケラチノサイト成長因子類似体
|
CN100398551C
(zh)
|
2001-11-09 |
2008-07-02 |
乔治敦大学 |
新的血管内皮细胞生长抑制剂同种型
|
ES2312649T3
(es)
|
2001-12-12 |
2009-03-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Inmunizacion frente a chlamydia trachomatis.
|
PT1472375E
(pt)
|
2002-01-08 |
2009-05-19 |
Novartis Vaccines & Diagnostic |
Produtos génicos expressos diferencialmente em células cancerígenas da mama e seus métodos de utilização
|
AU2003216288B2
(en)
|
2002-02-13 |
2009-09-24 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
FR2836043B1
(fr)
*
|
2002-02-15 |
2004-06-04 |
Inst Nat Sante Rech Med |
Vesicules lipidiques, preparation et utilisations
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
AU2003218350A1
(en)
|
2002-03-21 |
2003-10-08 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
JP2005535308A
(ja)
|
2002-06-13 |
2005-11-24 |
カイロン コーポレイション |
Hml−2ポリペプチド発現用ベクター
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
US20040208920A1
(en)
*
|
2002-07-03 |
2004-10-21 |
Dov Michaeli |
Liposomal vaccine
|
US7135324B2
(en)
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
UA80447C2
(en)
|
2002-10-08 |
2007-09-25 |
|
Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
|
WO2004043363A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
WO2004046177A2
(en)
|
2002-11-15 |
2004-06-03 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
ES2697876T3
(es)
|
2002-12-24 |
2019-01-29 |
Rinat Neuroscience Corp |
Anticuerpos anti-NGF y procedimientos de uso de los mismos
|
EP2058408A3
(en)
|
2003-02-14 |
2009-09-09 |
Sagres Discovery, Inc. |
Therapeutic GPCR targets in cancer
|
US7767387B2
(en)
|
2003-06-13 |
2010-08-03 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
WO2004073653A2
(en)
|
2003-02-19 |
2004-09-02 |
Rinat Neuroscience Corp. |
Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
CN1849112B
(zh)
*
|
2003-09-09 |
2012-06-13 |
吉里德科学公司 |
治疗性脂质体
|
AP2006003670A0
(en)
|
2003-12-23 |
2006-06-30 |
Rinat Neuroscience Corp |
Agonist anti-TRKC antibodies and methods using same
|
JP2007517892A
(ja)
*
|
2004-01-12 |
2007-07-05 |
マンカインド コーポレイション |
2型糖尿病における血清プロインスリンレベルを低下させる方法
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
CA2561696C
(en)
|
2004-03-29 |
2013-09-03 |
Galpharma Co., Ltd. |
Novel modified galectin 9 proteins and use thereof
|
US7223562B2
(en)
|
2004-03-31 |
2007-05-29 |
New York University |
Compositions for controlling hair growth
|
WO2005111077A2
(en)
|
2004-04-07 |
2005-11-24 |
Rinat Neuroscience Corp. |
Methods for treating bone cancer pain by administering a nerve growth factor antagonist
|
US20050255154A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Lena Pereswetoff-Morath |
Method and composition for treating rhinitis
|
CA2569513C
(en)
*
|
2004-06-04 |
2013-08-06 |
Camurus Ab |
Preformulation for liquid crystalline phase structure
|
PT1789593T
(pt)
|
2004-07-09 |
2017-04-24 |
Henry M Jackson Found Advancement Military Medicine Inc |
Formas solúveis de glicoproteína g de vírus hendra
|
US20060024677A1
(en)
|
2004-07-20 |
2006-02-02 |
Morris David W |
Novel therapeutic targets in cancer
|
NZ552480A
(en)
|
2004-07-30 |
2010-01-29 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods of using same
|
CN101010305B
(zh)
|
2004-08-20 |
2010-08-11 |
曼金德公司 |
二酮哌嗪合成的催化反应
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
DE05852057T1
(de)
|
2004-11-23 |
2007-11-29 |
Neuromolecular Pharmaceuticals Inc., Emeryville |
Zusammensetzung aus einer beschichtung oder matrix mit verzögerter freisetzung und einem nmda-rezeptorantagonisten sowie verfahren zur verabreichung eines solchen nmda-rezeptorantagonisten an ein subjekt
|
WO2006058236A2
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
US7939490B2
(en)
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
NZ580974A
(en)
|
2005-02-18 |
2011-05-27 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
CA2604052C
(en)
|
2005-04-06 |
2014-07-08 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of cns-related conditions
|
EP1910557A2
(en)
|
2005-04-07 |
2008-04-16 |
Chiron Corporation |
Cancer-related genes
|
EP2062591A1
(en)
|
2005-04-07 |
2009-05-27 |
Novartis Vaccines and Diagnostics, Inc. |
CACNA1E in cancer diagnosis detection and treatment
|
WO2007014169A2
(en)
|
2005-07-22 |
2007-02-01 |
Y's Therapeutics Co, Ltd. |
Anti-cd26 antibodies and methods of use thereof
|
US20070110674A1
(en)
*
|
2005-07-29 |
2007-05-17 |
Yuhong Xu |
Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems
|
AU2006290227B2
(en)
|
2005-09-14 |
2012-08-02 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
DK2380592T3
(en)
|
2005-11-14 |
2018-03-19 |
Teva Pharmaceuticals Int Gmbh |
Antagonist antibody directed to calcitonin gene related peptide
|
US20070154546A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Zhang Jack Y |
Sustained release pharmaceutical compositions
|
DK1986679T3
(da)
|
2006-02-22 |
2017-11-20 |
Mannkind Corp |
Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
|
JP2009533471A
(ja)
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
JP5313886B2
(ja)
|
2006-06-07 |
2013-10-09 |
バイオアライアンス セー.フェー. |
癌細胞で発現するcd−43およびceaの炭水化物含有エピトープを認識する抗体およびそれを使用する方法
|
PT2054431E
(pt)
|
2006-06-09 |
2011-11-03 |
Novartis Ag |
Confórmeros de adesinas bacterianas
|
US20100166788A1
(en)
|
2006-08-16 |
2010-07-01 |
Novartis Vaccines And Diagnostics |
Immunogens from uropathogenic escherichia coli
|
WO2008116032A1
(en)
|
2007-03-21 |
2008-09-25 |
Effat Emamian |
Compositions and methods for inhibiting tumor cell growth
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
EP2155777A2
(en)
|
2007-04-10 |
2010-02-24 |
The Administrators of the Tulane Educational Fund |
Soluble and membrane-anchored forms of lassa virus subunit proteins
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
CN102216329A
(zh)
|
2007-12-17 |
2011-10-12 |
辉瑞有限公司 |
间质性膀胱炎的治疗
|
WO2009079649A1
(en)
|
2007-12-18 |
2009-06-25 |
Bioalliance C.V. |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
US10000568B2
(en)
|
2008-04-10 |
2018-06-19 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR in cancer
|
US8900627B2
(en)
*
|
2008-06-06 |
2014-12-02 |
Mirna Therapeutics, Inc. |
Compositions for the in vivo delivery of RNAi agents
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA2728230C
(en)
|
2008-06-13 |
2017-10-17 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
AU2009259883B2
(en)
|
2008-06-20 |
2015-02-05 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
EP2344133B1
(en)
*
|
2008-10-07 |
2019-06-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
WO2010086828A2
(en)
|
2009-02-02 |
2010-08-05 |
Rinat Neuroscience Corporation |
Agonist anti-trkb monoclonal antibodies
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
RU2011140508A
(ru)
|
2009-03-06 |
2013-04-20 |
Новартис Аг |
Антигены хламидии
|
US8538707B2
(en)
|
2009-03-11 |
2013-09-17 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
PL2510947T3
(pl)
|
2009-04-14 |
2016-09-30 |
|
Kompozycje do immunizacji przeciwko Staphylococcus aureus
|
US20100305500A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Pacira Pharmaceuticals, Inc. |
Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
|
SG176738A1
(en)
|
2009-06-12 |
2012-01-30 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
ES2526996T3
(es)
|
2009-07-16 |
2015-01-19 |
Novartis Ag |
Inmunógenos desintoxicados de Escherichia coli
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
CN102883601A
(zh)
|
2009-12-02 |
2013-01-16 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
AR080291A1
(es)
|
2010-02-24 |
2012-03-28 |
Rinat Neuroscience Corp |
Anticuerpos antagonistas anti receptor de il-7 y procedimientos
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
MX2012010481A
(es)
|
2010-03-11 |
2012-10-09 |
Rinat Neuroscience Corp |
Anticuerpos con union de antigenos dependiente del ph.
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
US9770414B2
(en)
|
2010-05-13 |
2017-09-26 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
|
EP2582421A1
(en)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
Dry powder drug delivery system and methods
|
WO2012015758A2
(en)
|
2010-07-30 |
2012-02-02 |
Saint Louis University |
Methods of treating pain
|
US10610486B2
(en)
*
|
2010-10-28 |
2020-04-07 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of a non-steroidal anti-inflammatory drug
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
CN103153285B
(zh)
*
|
2010-12-27 |
2016-10-12 |
泰尔茂株式会社 |
脂质体组合物及其制造方法
|
CN103347892B
(zh)
|
2011-01-06 |
2016-11-02 |
比奥诺尔免疫有限公司 |
单体和多聚体免疫原性肽
|
WO2012118796A1
(en)
|
2011-02-28 |
2012-09-07 |
The Schepens Eye Research Institute, Inc. |
Compositions for controlling neuronal outgrowth
|
ES2625858T3
(es)
|
2011-04-01 |
2017-07-20 |
Mannkind Corporation |
Paquete de tipo blíster para cartuchos farmacéuticos
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US20130071375A1
(en)
|
2011-08-22 |
2013-03-21 |
Saint Louis University |
Compositions and methods for treating inflammation
|
WO2013028527A1
(en)
|
2011-08-23 |
2013-02-28 |
Indiana University Research And Technology Corporation |
Compositions and methods for treating cancer
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
RU2480479C1
(ru)
*
|
2011-11-01 |
2013-04-27 |
Елена Викторовна Свирщевская |
Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
|
CA2854720C
(en)
|
2011-11-11 |
2018-12-18 |
Rinat Neuroscience Corp. |
Antibodies specific for trop-2 and their uses
|
US9249224B2
(en)
|
2011-12-22 |
2016-02-02 |
Rinat Neuroscience Corp. |
Human growth hormone receptor antagonist antibodies and methods of use thereof
|
WO2013093693A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Staphylococcus aureus specific antibodies and uses thereof
|
US9668974B2
(en)
|
2012-05-10 |
2017-06-06 |
Painreform Ltd. |
Depot formulations of a local anesthetic and methods for preparation thereof
|
FR2991196B1
(fr)
*
|
2012-05-29 |
2014-06-27 |
Capsum |
Nanoparticules ciblantes pour une application biologique
|
US9421245B2
(en)
|
2012-06-25 |
2016-08-23 |
The Brigham And Women's Hospital, Inc. |
Targeted therapeutics
|
US20150191702A1
(en)
|
2012-07-02 |
2015-07-09 |
Commonwealth Scientific And Industrial Research Organization |
Paramyxovirus and Methods of Use
|
WO2014012069A2
(en)
|
2012-07-12 |
2014-01-16 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
EP3326613A1
(en)
|
2012-07-26 |
2018-05-30 |
Camurus AB |
Opioid formulations
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
CA2890483A1
(en)
|
2012-11-09 |
2014-05-15 |
Robert ARCH |
Platelet-derived growth factor b specific antibodies and compositions and uses thereof
|
SG11201504258RA
(en)
|
2012-11-30 |
2015-07-30 |
Glaxosmithkline Biolog Sa |
Pseudomonas antigens and antigen combinations
|
ES2853935T3
(es)
|
2013-03-12 |
2021-09-20 |
Massachusetts Gen Hospital |
Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades
|
US9708354B2
(en)
|
2013-03-15 |
2017-07-18 |
Cerenis Therapeutics Holding Sa |
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
|
CN105051068A
(zh)
|
2013-03-15 |
2015-11-11 |
戴埃克斯有限公司 |
抗血浆激肽释放酶抗体
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
CA2902565C
(en)
|
2013-03-15 |
2022-11-29 |
Loma Linda University |
Treatment of autoimmune diseases
|
US20140316154A1
(en)
|
2013-03-15 |
2014-10-23 |
Cerenis Therapeutics Holding Sa |
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
|
SG11201508264UA
(en)
|
2013-05-07 |
2015-11-27 |
Rinat Neuroscience Corp |
Anti-glucagon receptor antibodies and methods of use thereof
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
BR112016000937A8
(pt)
|
2013-07-18 |
2021-06-22 |
Mannkind Corp |
formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
|
FR3008900B1
(fr)
*
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
PE20160671A1
(es)
|
2013-08-02 |
2016-07-09 |
Pfizer |
Anticuerpos anti-cxcr4 y conjugados de anticuerpo y farmaco
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
SG11201602671WA
(en)
|
2013-11-13 |
2016-05-30 |
Pfizer |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
WO2015087187A1
(en)
|
2013-12-10 |
2015-06-18 |
Rinat Neuroscience Corp. |
Anti-sclerostin antibodies
|
EP3079712B1
(en)
|
2013-12-11 |
2022-02-02 |
The General Hospital Corporation |
Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
CA2943551A1
(en)
|
2014-03-21 |
2015-09-24 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2015164283A1
(en)
|
2014-04-21 |
2015-10-29 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an organic acid excipient
|
CA2946281C
(en)
|
2014-04-21 |
2022-12-13 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
WO2018048460A1
(en)
|
2014-04-21 |
2018-03-15 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
EP3139955B1
(en)
|
2014-04-30 |
2024-03-20 |
President and Fellows of Harvard College |
Fusion proteins for treating cancer and related methods
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗pd-1抗體類和使用彼等之方法
|
WO2016118652A1
(en)
*
|
2015-01-21 |
2016-07-28 |
Pacira Pharmaceuticals, Inc. |
Multivesicular liposome formulations of tranexamic acid
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
ES2905315T3
(es)
|
2015-04-13 |
2022-04-07 |
Pfizer |
Anticuerpos terapéuticos y sus usos
|
US10877045B2
(en)
|
2015-07-21 |
2020-12-29 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
CA2993026A1
(en)
|
2015-07-21 |
2017-01-26 |
Dyax Corp. |
A monoclonal antibody inhibitor of factor xiia
|
EP3325010B1
(en)
|
2015-07-23 |
2023-06-21 |
The Regents of The University of California |
Antibodies to coagulation factor xia and uses thereof
|
WO2017029583A2
(en)
|
2015-08-19 |
2017-02-23 |
Pfizer Inc. |
Tissue factor pathway inhibitor antibodies and uses thereof
|
CN113896790A
(zh)
|
2015-09-15 |
2022-01-07 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其用途
|
CN109071648B
(zh)
|
2015-10-23 |
2022-07-19 |
辉瑞有限公司 |
抗il-2抗体及其组合物和用途
|
WO2017075037A1
(en)
|
2015-10-27 |
2017-05-04 |
Scholar Rock, Inc. |
Primed growth factors and uses thereof
|
CN106699889A
(zh)
|
2015-11-18 |
2017-05-24 |
礼进生物医药科技(上海)有限公司 |
抗pd-1抗体及其治疗用途
|
AU2016381964B2
(en)
|
2015-12-30 |
2024-02-15 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
JP6902033B2
(ja)
|
2015-12-30 |
2021-07-14 |
アダマス ファーマシューティカルズ, インコーポレイテッド |
発作−関連障害の処置のための方法および組成物
|
US10221242B2
(en)
|
2016-01-21 |
2019-03-05 |
Pfizer Inc. |
Antibodies specific for epidermal growth factor receptor variant III and their uses
|
CN109983013A
(zh)
|
2016-11-18 |
2019-07-05 |
帕西拉制药有限公司 |
美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
|
KR102069670B1
(ko)
*
|
2017-03-02 |
2020-01-23 |
단디바이오사이언스 주식회사 |
면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
|
JP2020510435A
(ja)
|
2017-03-03 |
2020-04-09 |
ライナット ニューロサイエンス コーポレイション |
抗gitr抗体およびその使用方法
|
JP7177076B2
(ja)
|
2017-03-16 |
2022-11-22 |
ファイザー・インク |
チロシン原栄養性
|
US11584790B2
(en)
|
2017-04-14 |
2023-02-21 |
Kodiak Sciences Inc. |
Complement factor D antagonist antibodies and conjugates thereof
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
MX2019014465A
(es)
|
2017-06-02 |
2020-01-23 |
Pfizer |
Anticuerpos especificos para flt3 y sus usos.
|
EP3879535A1
(en)
|
2017-06-13 |
2021-09-15 |
BostonGene Corporation |
Systems and methods for identifying cancer treatments from normalized biomarker scores
|
AU2018301442A1
(en)
|
2017-07-13 |
2020-01-30 |
Massachusetts Institute Of Technology |
Targeting the HDAC2-Sp3 complex to enhance synaptic function
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
JP2020536115A
(ja)
|
2017-10-04 |
2020-12-10 |
オプコ ファーマシューティカルズ、エルエルシー |
癌の個別化療法に関する物品および方法
|
PE20211299A1
(es)
|
2018-02-01 |
2021-07-20 |
Pfizer |
Receptores de antigeno quimericos dirigidos a cd70
|
BR112020015641A2
(pt)
|
2018-02-01 |
2021-01-05 |
Pfizer Inc. |
Anticorpos específicos para cd70 e seus usos
|
CN112513070A
(zh)
|
2018-02-28 |
2021-03-16 |
辉瑞公司 |
Il-15变体及其用途
|
PE20210488A1
(es)
|
2018-05-23 |
2021-03-15 |
Pfizer |
Anticuerpos especificos para gucy2c y sus usos
|
AU2019274654B2
(en)
|
2018-05-23 |
2023-07-20 |
Pfizer Inc. |
Antibodies specific for CD3 and uses thereof
|
JP2022538499A
(ja)
|
2019-07-03 |
2022-09-02 |
ボストンジーン コーポレイション |
サンプル調製、サンプルシークエンシング、およびシークエンシングデータのバイアス補正と品質管理のためのシステムならびに方法
|
WO2021011299A1
(en)
*
|
2019-07-12 |
2021-01-21 |
Pacira Pharmaceuticals, Inc. |
Multivesicular liposome formulations of dexmedetomidine
|
CA3139748A1
(en)
*
|
2019-08-01 |
2021-02-04 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
US11788091B2
(en)
|
2019-08-21 |
2023-10-17 |
University Of Virginia Patent Foundation |
Methods and compositions for diagnosing and treating prostate cancer based on long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth
|
EP4041308A1
(en)
|
2019-10-07 |
2022-08-17 |
University of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
CA3152623A1
(en)
|
2019-10-11 |
2021-04-15 |
Richard D. Cummings |
Anti-tn antibodies and uses thereof
|
WO2021146215A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
EP4093426A1
(en)
|
2020-01-24 |
2022-11-30 |
University of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
WO2021205325A1
(en)
|
2020-04-08 |
2021-10-14 |
Pfizer Inc. |
Anti-gucy2c antibodies and uses thereof
|
US20230181750A1
(en)
|
2020-05-06 |
2023-06-15 |
Crispr Therapeutics Ag |
Mask peptides and masked anti-ptk7 antibodies comprising such
|
AU2021308586A1
(en)
|
2020-07-17 |
2023-03-02 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
WO2022023972A1
(en)
|
2020-07-30 |
2022-02-03 |
Pfizer Inc. |
Cells having gene duplications and uses thereof
|
AU2021338361A1
(en)
|
2020-09-03 |
2023-04-06 |
Chen, Irvin S.Y |
Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs
|
WO2022120256A2
(en)
|
2020-12-04 |
2022-06-09 |
Bostongene Corporation |
Hierarchical machine learning techniques for identifying molecular categories from expression data
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US20220372580A1
(en)
|
2021-04-29 |
2022-11-24 |
Bostongene Corporation |
Machine learning techniques for estimating tumor cell expression in complex tumor tissue
|
CA3227875A1
(en)
|
2021-08-02 |
2023-02-09 |
Pfizer Inc. |
Improved expression vectors and uses thereof
|
WO2023147177A1
(en)
|
2022-01-31 |
2023-08-03 |
Bostongene Corporation |
Machine learning techniques for cytometry
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
WO2024015561A1
(en)
|
2022-07-15 |
2024-01-18 |
Bostongene Corporation |
Techniques for detecting homologous recombination deficiency (hrd)
|
CN115486539A
(zh)
*
|
2022-09-14 |
2022-12-20 |
厦门遇见今生生物科技有限公司 |
具有抗衰老及端粒延长的草药提取物仿生膜及其制备方法
|